Barcelona, Spain – Building and nurturing relationships is an essential part of the progression of successful business partnerships. BIO-Europe Spring 2024 will offer a fusion of innovative digital solutions and a vibrant on-site event of unprecedented scope.
Expanding on the success of EBD Group’s flagship conference, BIO-Europe® , BIO-Europe Spring will bring together over 3,700 leading executives from around the world.
They will host more than 20,000 partnering meetings to connect leaders from academia, start-up, and scale-up biotech companies with forward-thinking investors and pharma companies.
Along with world-class workshops and panels, innovative company presentations, active exhibition and a variety of networking opportunities make this event an unrivalled forum for companies across the biotech value chain to meet and do business.
For further details about the congress, including registration and abstract submission, please click here.
Speakers
Khatereh Ahmadi – Head of Search and Evaluation Team at MSD
Lilian Alcaraz – VP of Early Innovation Partnering at Johnson & Johnson Innovation
Laura Faravelli – VP Business Development at NEWRON PHARMACEUTICALS SPA
Sean Jou – President & Chief Scientific Officer at HanchorBio Inc.
Laura Lane – VP – Venture Sciences (Europe) at Eli Lilly & Co
Victoria Balannik – VP and Global Head of External Innovation at Menarini Stemline
Jared Bauer – CEO at Seek Labs
Seth Lederman – CEO at Tonix Pharmaceuticals Holding Corp.
Congress at a glance
When: March 18-20 2024